Statement of use

Mitsubishi Tanabe Pharma Corporation has reported the information cited in this GRI Standard Comparative Table for the period from April 1, 2024, to March 31, 2025, with reference to the GRI Standards.

GRI 1 used

GRI 1: Foundation 2021

General Disclosures

1. The organization and its reporting practices

Disclosure

Page

General Disclosures 2021

2-1

Organizational details

Corporate Profile

Network

Group Companies

2-2

Entities included in the organization’s sustainability reporting

Network

Group Companies

2-3

Reporting period, frequency and contact point

Editorial Policies

2. Activities and workers

GeneralDisclosures 2021

2-6

Activities, value chain and other business relationships

Corporate Profile

2-7

Employees

Corporate Profile

Data (Together with Employees)

2-8

Workers who are not employees

Data (Together with Employees)

3. Governance

GeneralDisclosures 2021

2-9

Governance structure and composition

About Us

2-12

Role of the highest governance body in overseeing the management of impacts

Environmental Management

2-13

Delegation of responsibility for managing impacts

Environmental Management (EnvironmentalManagement Promotion System)

2-16

Communication of critical concerns

Risk Management

Environmental Management 

4. Strategy, policies and practices

GeneralDisclosures 2021

2-22

Statement on sustainable development strategy

About Us

2-23

Policy commitments

Policies

Respect for Human Rights

2-24

Embedding policy commitments

Compliance

Respect for Human Rights

2-25

Processes to remediate negative impacts

Compliance

Respect for Human Rights

2-26

Mechanisms for seeking advice and raising concerns

Compliance

Respect for Human Rights

2-27

Compliance with laws and regulations

Compliance

Environmental Management (Status of Environmental Accidents/Violations of Environmental Laws and Regulations)

2-28

Membership associations

KEIDANREN (Japan Business Federation),Federation of Pharmaceutical Manufacturers’Associations of Japan, Japan PharmaceuticalManufacturers Association, etc.

5. Stakeholder engagement

GeneralDisclosures 2021

2-29

Approach to stakeholder engagement

Stakeholder Engagement

2-30

Collective bargaining agreements

Promoting Diversity & Inclusion (BuildingSound Labor-Management Relations)

Material Topics

Disclosure

Page

Material Topics2021

3-1

Process to determine material topics

Materiality

3-2

List of material topics

Materiality

3-3

Management of material topics

Risk Management

Economic

Indirect Economic Impacts

Disclosure

Page

GRI 203:

Indirect EconomicImpacts 2016

203-1

Infrastructure investments and services supported

Solving Issues Related to Improving Access to Healthcare

Anti-corruption

GRI 205:

Anti-corruption2016

205-1

Operations assessed for risks related to corruption

Promotion of Fair Operating Practices (Initiatives to Prevent Bribery andCorruption)

205-2

Communication and training about anti-corruption policies and procedures

Promotion of Fair Operating Practices (Initiatives to Prevent Bribery andCorruption)

Compliance

GRI207:

Tax 2019

207-1

Approach to tax

Global Tax Policy

207-2

Tax governance, control, and risk management

Global Tax Policy

207-3

Stakeholder engagement and management of concerns relatedto tax

Global Tax Policy

Environmental

Energy

Disclosure

Page

GRI 302:

Energy 2016

302-1

Energy consumption within the organization

Targets & Initiatives (Material balance)

Climate Change Initiatives

302-2

Energy consumption outside of the organization

Climate Change Initiatives (Supply ChainGreenhouse Gas Emissions ReductionOverview)

302-3

Energy intensity

Climate Change Initiatives (Reduction ofGreenhouse Gas (GHG) Emissions)

302-4

Reduction of energy consumption

Climate Change Initiatives

Water

GRI 303:

Water and

Effluents 2018

303-1

Interactions with water as a shared resource

Targets & Initiatives (Material balance)

Water Resource Initiatives

303-2

Management of water discharge-related impacts

Initiatives to Prevent Pollution (WaterPollution, Prevention of Soil andGroundwater)

303-3

Water withdrawal

Targets & Initiatives (Material balance)

Water Resource Initiatives

303-5

Water consumption

Water Resource Initiatives

Biodiversity

GRI 304:

Biodiversity 2016

304-3

Habitats protected or restored

Biodiversity Initiatives

Emissions

GRI 305:

Emissions 2016

305-1

Direct (Scope 1) GHG emissions

Targets & Initiatives (Material balance)

Climate Change Initiatives (Supply ChainGreenhouse Gas Emissions ReductionOverview)

305-2

Energy indirect (Scope 2) GHGemissions

Targets & Initiatives (Material balance)

Climate Change Initiatives (Supply ChainGreenhouse Gas Emissions ReductionOverview)

305-3

Other indirect (Scope 3) GHGemissions

Climate Change Initiatives (Supply ChainGreenhouse Gas Emissions ReductionOverview)

305-5

Reduction of GHG emissions

Climate Change Initiatives (Supply ChainGreenhouse Gas Emissions ReductionOverview)

305-7

Nitrogen oxides (NOx), sulfur oxides (SOx), and other significant air emissions

Targets & Initiatives (Material balance)

Initiatives to Prevent Pollution (Air PollutantEmissions)

Waste

GRI 306:

Waste 2020

306-1

Waste generation and significant waste-related impacts

Targets & Initiatives(Material balance)

Initiatives to Reduce Waste and RecycleResources

306-2

Management of significant waste-related impacts

Targets & Initiatives(Material balance)

Initiatives to Reduce Waste and RecycleResources

306-3

Waste generated

Targets & Initiatives(Material balance)

Initiatives to Reduce Waste and RecycleResources

306-5

Waste directed to disposal

Targets & Initiatives(Material balance)

Initiatives to Reduce Waste and RecycleResources

Social

Employment

Disclosure

Page

GRI 401:

Employment 2016

401-1

New employee hires and employee turnover

Data (Together with Employees)

401-3

Parental leave

Promoting Diversity & Inclusion (Support forDiverse Working Styles)

Data (Together with Employees)

Occupational Health and Safety

GRI 403:

OccupationalHealth and Safety2018

403-1

Occupational health and safety management system

Occupational Health and Safety

403-2

Hazard identification, risk assessment, and incident investigation

Occupational Health and Safety

403-3

Occupational health services

Occupational Health and Safety

403-4

Worker participation,

consultation, and communication on occupational health and safety

Occupational Health and Safety

403-5

Worker training on occupational health and safety

Occupational Health and Safety

403-6

Promotion of worker health

Occupational Health and Safety

Health and Productivity Management

403-7

Prevention and mitigation of occupational health and safety impacts directly linked by business relationships

Occupational Health and Safety

403-8

Workers covered by an occupational health and safety management system

Data (Occupational Health and Safety)

403-9

Work-related injuries

Occupational Health and Safety

403-10

Work-related ill health

Occupational Health and Safety

Health and Productivity Management

Data (Occupational Health and Safety,Health and Productivity Management)

Training and Education

GRI 404:

Training and

Education 2016

404-1

Average hours of training per year per employee

Human Resources Development

404-2

Programs for upgrading employee skills and transition assistance programs

Human Resources Development

Diversity and Equal Opportunity

GRI 405:

Diversity and Equal Opportunity 2016

405-1

Diversity of governance bodies and employees

Data (Together with Employees)

Human Rights Assessment

GRI 412:

Human Rights

Assessment 2016

412-2

Employee training on human rights policies or procedures

Respect for Human Rights

Local Communities

GRI 413:

Local Communities

2016

413-1

Operations with local community engagement, impact assessments, and development programs

Promotion of Local Communities (Historical Museum, Doshomachi Museum Street, The Doshomachi Club, etc.)

Customer Health and Safety

GRI 416:

Customer Health

and Safety 2016

416-1

Assessment of the health and safety impacts of product and service categories

Stable Supply

Drug Safety / Quality Assurance

Marketing and Labeling

GRI 417:

Marketing and

Labeling 2016

417-1

Requirements for product and service information and labeling

Information Provision

Stable Supply

Promotion of Fair Operating Practices